Ionic Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-70,000
Closed -$8.08M 277
2023
Q2
$8.08M Buy
+70,000
New +$7.95M 2.31% 7
2018
Q1
Sell
-235,800
Closed -$12.7M 308
2017
Q4
$12.7M Sell
235,800
-104,800
-31% -$5.81M 0.52% 37
2017
Q3
$20.8M Sell
340,600
-26,200
-7% -$1.59M 0.84% 19
2017
Q2
$22.4M Sell
366,800
-52,400
-13% -$3.19M 1.2% 18
2017
Q1
$25.4M Buy
419,200
+340,600
+433% +$20.7M 1.56% 10
2016
Q4
$4.42M Buy
78,600
+52,400
+200% +$3.07M 0.24% 121
2016
Q3
$1.56M Hold
26,200
0.07% 205
2016
Q2
$1.44M Buy
+26,200
New +$1.39M 0.06% 189
2015
Q2
Sell
-18,340
Closed -$1.01M 312
2015
Q1
$1.01M Buy
+18,340
New +$1.04M 0.04% 192
2013
Q3
Sell
-40,453
Closed -$1.79M 261
2013
Q2
$1.79M Buy
+40,453
New +$1.81M 0.05% 196

Other funds holding MRK

Ionic Capital Management's MRK Position: Q1 2022 in Review

Ionic Capital Management sold out of Merck (MRK) in Q1 2022, closing a stake of 3,530 shares — an estimated $271K sold.

Ionic Capital Management first reported a position in MRK in Q1 2017 and held it in 6 quarters. The position peaked at $9.91M in Q4 2017. 2,952 funds tracked by Wall St. Rank hold MRK as of Q1 2022.

  • Ionic Capital Management reported no remaining Merck position as of Q1 2022 after selling out during the quarter.
  • Ionic Capital Management sold 3,530 Merck shares in Q1 2022, an estimated $271K.
  • Ionic Capital Management first reported a position in Merck in Q1 2017 and held it in 6 quarters.
  • Ionic Capital Management's Merck position peaked at $9.91M in Q4 2017.
  • 2,952 funds tracked by Wall St. Rank held Merck as of Q1 2022.

Based on Ionic Capital Management's 13F filing for Q1 2022, filed 16 May 2022.